Table 5.
In-Hospital Outcomes of COVID NSTE-ACS and MINAP NSTE-ACS Subgroups
| COVID NSTE-ACS Total (n = 121) | MINAP 2019 | p Value | |
|---|---|---|---|
| Death | 6.6 (8/121) | 1.2 (378/32546) | <0.001 |
| Myocardial infarction | 4.1 (5/121) | N/A | |
| Heart failure | 19.0 (23/121) | N/A | |
| Stent thrombosis | 0.0 (0/121) | N/A | |
| Bleeding (Bleeding Academic Research Consortium 3–5) | 2.5 (3/121) | 0.12 (28/22,445) | 0.006 |
| Stroke | 0.8 (1/121) | 0.05 (18/33,352) | 0.067 |
| Cardiogenic shock | 5.0 (6/121) | 1.4 (461/33,342) | 0.007 |
| In-patient stay, days | 6.9 (3.4–18.4) | 5.0 (3.0–8.0) | <0.001 |
Values are % (n/N) or median (interquartile range). Bold p values indicate statistical significance.
Abbreviations as in Table 1.